Floppy iris syndrome as a complication of the use of an alpha-adrenergic blocker for the treatment of benign prostatic hyperplasia

• Autor(a) principal: Assunção, Izabely Lima
• Data de Publicação: 2021
• Outros Autores: Mendes, Ana Karoline de Almeida, Fonseca , Gustavo Soares Gomes Barros, Normando , Lara Vasconcelos, Leite, Felipe de Queiroz, Miranda , Lise Feitosa Novais, Melo , Pryscilla Oliveira, Dias , Nikole Sousa, Silva , Valéria Marques da, Cunha , Rebeca Xavier Fontes, Adler, Giovanna de Paiva, Nunes , Raissa de Sousa, Paz , João Victor Carvalho da, Silva, Ana Letícia Lopes Abreu, Souza, Marcos Vijano da Silva, Costa, Arthur Brício Silva, Abreu , David Brusaca, Pereira , Sarah Barreto Ramos, Barreto, Fernanda Nogueira, Coelho, Claudia Nery do Nascimento, Silva , Chelsea Magalhães Tavares da, Freitas Júnior, Wellington Ubaldino de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/21626
• topic: Benign prostatic hyperplasia; Intraoperative flaccid iris syndrome; Alpha 1 adrenergic receptor antagonists.; Benign prostatic hyperplasia; Intraoperative flaccid iris syndrome; Alpha 1 adrenergic receptor antagonists.; Hiperplasia prostática benigna; Síndrome da íris flácida intraoperatória; Antagonistas de receptores alfa 1 adrenérgicos.

Benign prostatic hyperplasia (BPH) is a urinary alteration associated with symptoms in the lower urinary tract, which can be voiding urgency, pollakiuria, voiding effort and bladder tenesmus. Meta-blockers, used in drug treatment in some cases of BPH, can inhibit the muscles responsible for iris dilation, leading to the development of alphab intraoperative iris syndrome (SIFI). Thus, the aim of the following review was to relate alpha 1 adrenergic receptor antagonists in the treatment of BPH with the development of SIFI. This is a systematic literature review that uses the platforms PubMed, sciELO and Google Scholar as a database for researching scientific articles, with a time frame between 2016 and 2021, in English. According to the search engine, 10 results were found, 10 articles in the PubMed and Google Scholar databases and 0 in the SciELO database. Therefore, according to the literature analyzed, the relationship between the use of alpha-1 adrenergic receptor antagonists, especially tamsulosin, for the treatment of BPH and the development of SIFI was found.